Vyne Therapeutics Inc. (VYNE) SEC Filings — 2025
11 SEC filings for Vyne Therapeutics Inc. (VYNE) in 2025.
Filings
- VYNE Therapeutics Reports Material Agreements & Executive Changes — 8-K · Dec 17, 2025
- Vyne Therapeutics Inc. 8-K Filing — 8-K · Dec 12, 2025
- VYNE Sets Dec 12 Shareholder Meeting for Director Election, Auditor Ratification — DEF 14A · Nov 12, 2025
- VYNE Narrows Losses Amid Clinical Setbacks, Initiates Strategic Review — 10-Q · Nov 6, 2025
- VYNE Therapeutics Faces Delisting Concerns — 8-K · Sep 12, 2025
- VYNE Therapeutics Files 8-K on Financials and Personnel — 8-K · Aug 14, 2025
- VYNE Therapeutics Narrows Loss Amid Clinical Setbacks, Strategic Pivot — 10-Q · Aug 14, 2025
- VYNE Therapeutics Files 8-K on Operations and Events — 8-K · Jul 30, 2025
- VYNE Therapeutics Files Q1 2025 10-Q — 10-Q · May 8, 2025
- VYNE Therapeutics Files 2024 10-K — 10-K · Mar 6, 2025
- VYNE Therapeutics Files 8-K: Other Events & Exhibits — 8-K · Jan 13, 2025